An all-atom, active site exploration of antiviral drugs that target Flaviviridae polymerases
Jazyk angličtina Země Velká Británie, Anglie Médium print-electronic
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
27489039
DOI
10.1099/jgv.0.000569
Knihovny.cz E-zdroje
- MeSH
- antivirové látky chemie farmakologie MeSH
- DNA řízené RNA-polymerasy antagonisté a inhibitory chemie metabolismus MeSH
- Flaviviridae chemie účinky léků enzymologie genetika MeSH
- katalytická doména MeSH
- lidé MeSH
- nukleosidy chemie metabolismus MeSH
- racionální návrh léčiv MeSH
- vazebná místa MeSH
- virové proteiny antagonisté a inhibitory chemie genetika metabolismus MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- antivirové látky MeSH
- DNA řízené RNA-polymerasy MeSH
- nukleosidy MeSH
- virové proteiny MeSH
Natural 2'-modified nucleosides are the most widely used antiviral therapy. In their triphosphorylated form, also known as nucleotide analogues, they target the active site of viral polymerases. Viral polymerases have an overall right-handed structure that includes the palm, fingers and thumb domains. These domains are further subdivided into structurally conserved motifs A-G, common to all viral polymerases. The structural motifs encapsulate the allosteric/initiation (N1) and orthosteric/catalytic (N2) nucleotide-binding sites. The current study investigated how nucleotide analogues explore the N2 site of viral polymerases from three genera of the family Flaviviridae using a stochastic, biophysical, Metropolis Monte Carlo-based software. The biophysical simulations showed a statistical distinction in nucleotide-binding energy and exploration between phylogenetically related viral polymerases. This distinction is clearly demonstrated by the respective analogue contacts made with conserved viral polymerase residues, the heterogeneous dynamics of structural motifs, and the orientation of the nucleotide analogues within the N2 site. Being able to simulate what occurs within viral-polymerase-binding sites can prove useful in rational drug designs against viruses.
Citace poskytuje Crossref.org
New opportunities for designing effective small interfering RNAs